Past Issue - March 2014 - Vol 17 Issue 2 Index | Previous | Next | 
2014;17;E119-E128. Assessment of the Trends in Medical Use and Misuse of Opioid Analgesics from 2004 to 2011
Health Policy Research
Sairam Atluri, MD, Gururau Sudarshan, MD, and Laxmaiah Manchikanti, MD
 

BACKGROUND: The epidemic of medical use and abuse of opioid analgesics is linked to the economic burden of opioid-related abuse and fatalities in the United States. Multiple studies have estimated the extent to which prescription opioid analgesics contribute to the national drug abuse problem; studies also assessing the trends in medical use and abuse of opioid analgesics have confirmed the relationship between increasing medical use of opioids and increasing fatalities.
The available data is limited until 2002.
STUDY DESIGN: Retrospective analysis of data from 2004 to 2011 from 2 databases: Automation of Reports and Consolidated Orders System (ARCOS) for opioid use data and Drug Abuse Warning Network (DAWN) for drug misuse data.
OBJECTIVE: To determine the proportion of drug abuse related to opioid analgesics and the various trends in the medical use and abuse of 8 opioid analgesics commonly used to treat pain: buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, and oxycodone.
METHODS: The data obtained from DAWN is a nationally representative sample of hospital emergency department admissions resulting from drug abuse.
Main outcome measure was the identification of trends in the medical use and misuse of opioid analgesics from 2004 to 2011.
RESULTS: From 2004 to 2011, there was an increase in the medical use of all opioids except for a 20% decrease in codeine. The abuse of all opioids including codeine increased during this period. Increases in medical use ranged from 2,318% for buprenorphine to 35% for fentanyl, including 140% for hydromorphone, 117% for oxycodone, 73% for hydrocodone, 64% for morphine, and 37% for methadone. The misuse increased 384% for buprenorphine with available data from 2006 to 2011, whereas from 2004 to 2011, it increased 438% for hydromorphone, 263% for oxycodone, 146% for morphine, 107% for hydrocodone, 104% for fentanyl, 82% for methadone, and 39% for codeine.
Comparison of opioid use showed an overall increase of 1,448% from 1996 to 2011, with increases if 690% from 1996 to 2004 and 100% from 2004 to 2011. In contrast, misuse increased more dramatically: 4,680% from 1996 to 2011, with increases of 1,372% from 1996 through 2004 and 245% from 2004 to 2011. The number of patients seeking rehabilitation for substance abuse also increased 187% for opioids, whereas it increased 87% for heroin, 40% for marijuana, and decreased 7% for cocaine.
LIMITATIONS: Limitations of this assessment include the lack of data from 2003, lack of data available on meperidine, and that the aggregate data systems used in the study did not identify specific formulations or commercial products.
CONCLUSION: The present trend of continued increase in the medical use of opioid analgesics appears to contribute to increases in misuse, resulting in multiple health consequences.

 

   
 
Author Information
>> Manuscript Guidelines
Advertising
>> Rates
>> Ad format requirements

Quick Search in
PubMed
CrossRef
Pain Physcian
Authors
Sairam Atluri
Gururau Sudarshan
Laxmaiah Manchikanti


Keywords
Medical use of opioids
inappropriate use of opioids
abuse of opioids
opioid-related fatalities
Automation of Reports and Consolidated Orders System (ARCOS)
Drug Abuse Warning Network (DAWN)
International Narcotics Control Board (INCB)